Chronic Pancreatitis

Slide 1 · Chronic pancreatitis

Irreversible injury · fibrosis · loss of pancreatic function

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain how recurrent pancreatic injury produces irreversible fibrotic remodeling.

Recognize major causes, molecular susceptibility, and defining morphology.

Differentiate autoimmune pancreatitis phenotypes and carcinoma mimics.

Link exocrine and endocrine injury to clinical findings and diagnostic clues.

Slide 3 · Normal pancreas: Two functional compartments

EXOCRINE

Acinar cells synthesize digestive enzymes.

Duct epithelium conveys fluid and bicarbonate.

ENDOCRINE

Islets of Langerhans regulate blood glucose.

Endocrine loss generally occurs later in chronic disease.

This functional division predicts the sequence of clinical failure.

Slide 4 · The defining lesion is irreversible parenchymal destruction

Persistent inflammation → exocrine tissue loss + fibrosis

Structural / mechanistic meaning

Acinar dropout and ductal remodeling are central structural changes.

Clinical / interpretive meaning

With progression, loss of islet cells produces endocrine insufficiency.

Slide 5 · Recurrent injury drives a self-perpetuating process

Repeated acinar injury

Inflammatory mediators

Perilobular fibrosis

Duct distortion

Further injury and tissue loss

The progression model links recurrent acute episodes to irreversible chronic damage.

Slide 6 · Acute and chronic pancreatitis are not synonymous

Feature

Acute pancreatitis

Chronic pancreatitis

Principal injury

Potentially reversible acinar injury

Irreversible tissue loss

Dominant process

Enzyme activation and inflammation

Fibrogenic remodeling

Typical outcome

Resolution in many patients

Fibrosis and insufficiency

Microscopic clue

Edema ± necrosis

Acinar atrophy with fibrosis

Slide 7 · Etiologic groups form a coherent framework

Alcohol exposure

Long-term heavy alcohol use is the commonest cause cited.

Duct obstruction

Calculi or neoplasms block pancreatic outflow.

Immune-mediated disease

Autoimmune pancreatitis has distinct morphologic variants.

Inherited predisposition

Genetic susceptibility may coexist with acquired injury.

Slide 8 · Alcohol is the leading recognized association

Sustained alcohol exposure underlies many cases of chronic pancreatitis.

Ductal dilation, protein plugs, and calcifications are especially characteristic.

Exposure alone is insufficient to explain every case: Susceptibility varies.

Alcohol can also precipitate symptomatic pain attacks.

Slide 9 · Alcohol-related disease remodels the duct system

Long-term alcohol exposure

Altered duct secretions

Protein plugs and concretions

Duct dilation and plugging

Persistent parenchymal injury

Schematic links documented duct features; Mechanisms are multifactorial.

Slide 10 · Obstructed ducts can sustain parenchymal injury

Calculus or neoplasm

Blocked pancreatic outflow

Ductal pressure/distortion

Recurrent local injury

Fibrosis and acinar loss

Evaluate an obstructive process rather than assuming alcohol as the cause.

Slide 11 · Autoimmune pancreatitis is a separate pathogenic category

Type 1

IgG4-associated, part of systemic IgG4-related disease.

Type 2

Duct-centered neutrophilic lesions; May coexist with ulcerative colitis.

Type 3

Checkpoint-inhibitor–associated pancreatic injury.

Common pitfall

A focal or mass-like process can resemble pancreatic carcinoma.

Slide 12 · Inherited susceptibility changes the threshold for injury

Some recurrent acute attacks beginning in childhood lead to chronic fibrosis.

Inherited mechanisms often increase or prolong intrapancreatic trypsin activity.

PRSS1, SPINK1, and CFTR are emphasized in the adjacent Robbins section.

Genetic and environmental factors can act together.

Slide 13 · Pancreatitis-associated genes affect distinct safeguards

Gene

Alteration

Pathogenic effect

PRSS1

Gain of function

Persistent/greater trypsin activation

SPINK1

Loss of function

Weakened trypsin inhibition

CFTR

Loss of function

Viscous secretions and duct plugging

CTRC

Loss of function

Reduced trypsin degradation

Slide 14 · PRSS1 gain of function sustains trypsin activity

PRSS1 variant

Trypsinogen activation or resistance to self-inactivation

Persistent trypsin

Recurrent pancreatic injury

Autosomal-dominant hereditary pancreatitis with PRSS1 variants.

Slide 15 · SPINK1 deficiency weakens a local protective brake

Normal safeguard

SPINK1 encodes a trypsin inhibitor.

Adequate inhibitor limits inappropriate intrapancreatic activity.

Loss of function

Reduced inhibitor function favors sustained trypsin activity.

Recessive inheritance for this form.

Slide 16 · CFTR dysfunction favors duct obstruction

CFTR loss of function

Reduced bicarbonate-rich fluid secretion

More acidic, inspissated duct contents

Duct plugging

Pancreatic injury

CFTR-related pancreatitis may occur without classic cystic fibrosis findings.

Slide 17 · Other susceptibility genes emphasize calcium and enzymes

Gene

Protein function

Mechanistic implication

CASR

Calcium-sensing receptor

Calcium changes may facilitate trypsin activation

CTRC

Chymotrypsin C

Impaired degradation of trypsin

CPA1

Carboxypeptidase A1

Toxic gain of function in a zymogen-regulating enzyme

Slide 18 · Susceptibility and exposure are not mutually exclusive

Genetic predisposition

Environmental or obstructive stress

Recurrent pancreatic injury

Fibrotic response

A single patient may have more than one contributor; Avoid rigid etiologic labels.

Slide 19 · The bridge from acute to chronic disease is fibrosis

Acute acinar insult

Perilobular fibrogenesis

Recurrent bouts

Progressive acinar dropout

Irreversible scarred gland

A conceptual sequence, not a claim that every acute episode becomes chronic.

Slide 20 · Acinar injury releases inflammatory mediators

Repeated injury stimulates local inflammatory signaling.

In chronic disease, profibrotic effects become especially important.

Fibrogenic signals favor activated stellate cells and matrix deposition.

Progressive replacement by scar compromises exocrine tissue.

Slide 21 · Pancreatic stellate cells are central effectors

Chronic local injury

Profibrotic cytokines

Stellate-cell activation/proliferation

Collagen production

Parenchymal fibrosis

Stellate cells behave as periacinar myofibroblasts in the injured gland.

Slide 22 · TGF-β and PDGF promote fibrotic remodeling

TGF-β

Profibrotic signaling is prominent in chronic pancreatitis.

Supports extracellular-matrix accumulation.

PDGF

Supports stellate-cell activation and proliferation.

Promotes persistence of the fibroblastic response.

Slide 23 · Extracellular matrix replaces functioning acini

Editable architectural schematic

Intact

Remodeling

Scarred

Structural features

Intact lobules contain enzyme-producing acini.

Injury induces collagen deposition around lobules.

Extensive fibrosis leaves scattered residual glands.

Schematic — not a histologic specimen

Slide 24 · Duct distortion reinforces injury

Fibrotic remodeling

Duct distortion / luminal obstruction

Changed ductal secretions

Recurrent damage

Further fibrosis

Ductal pathology and parenchymal scarring can reinforce one another.

Slide 25 · Exocrine and endocrine injury follow different trajectories

Earlier / prominent

Acinar atrophy and dropout

Reduced digestive enzyme reserve

Later / progressive

Relative early preservation of islets

Diabetes when endocrine tissue is lost

Slide 26 · Gross morphology: A hard, scarred gland

Editable architectural schematic

Duct with concretions

Structural features

Firmness reflects replacement of parenchyma by fibrosis.

Ducts may be visibly dilated.

Calcified intraductal concretions may be present.

Schematic — not a histologic specimen

Slide 27 · Calcification points to chronic ductal disease

Ductal concretions are a structural clue, not the sole diagnostic criterion.

Structural / mechanistic meaning

They are particularly emphasized in alcohol-associated chronic pancreatitis.

Clinical / interpretive meaning

CT and ultrasonography can demonstrate intrapancreatic calcifications.

Slide 28 · Histology: Fibrosis and acinar loss coexist

Editable architectural schematic

Structural features

Broad fibrous areas partition residual parenchyma.

Acinar cell atrophy and dropout are defining.

Chronic inflammatory cells accompany the fibrotic process.

Schematic — not a histologic specimen

Slide 29 · Lobules and ducts attract chronic inflammation

Editable architectural schematic

Structural features

Inflammatory infiltrates surround lobules and ducts.

Inflammation accompanies rather than replaces fibrotic change.

Interpret architecture together with cell populations.

Schematic — not a histologic specimen

Slide 30 · Relative islet preservation creates an apparent paradox

Editable architectural schematic

Residual islets amid fibrosis

Structural features

Exocrine acini may be extensively lost.

Residual islets persist in the scarred stroma.

Islet aggregates can appear fused or enlarged.

Schematic — not a histologic specimen

Slide 31 · Pancreatic duct epithelium may undergo adaptation

Ductal change

Morphologic meaning

Dilation

Altered outflow and remodeling

Atrophy

Loss of epithelial volume

Hyperplasia

Reactive epithelial proliferation

Squamous metaplasia

Phenotypic adaptation under chronic injury

Slide 32 · Alcohol-associated ducts contain protein plugs

Editable architectural schematic

Intraluminal protein concretions

Structural features

Proteinaceous material accumulates within duct lumina.

Concretions may calcify.

Correlate ductal change with acinar atrophy and fibrosis.

Schematic — not a histologic specimen

Slide 33 · Morphologic recognition uses a constellation

Compartment

Expected observation

Interpretive relevance

Stroma

Collagen-rich fibrosis

Irreversible remodeling

Exocrine acini

Atrophy/dropout

Loss of secretion capacity

Ducts

Variable dilation ± plugs

Obstructive/secretory effects

Islets

Relative preservation early

Delayed endocrine failure

Slide 34 · Type 1 autoimmune pancreatitis: IgG4-related disease

Type 1 AIP is a pancreatic manifestation of IgG4-related disease.

Dense lymphoplasmacytic inflammation accompanies fibrosis.

Abundant IgG4-positive plasma cells support the tissue pattern.

The full histologic constellation matters more than one isolated feature.

Slide 35 · Storiform fibrosis is a distinctive tissue pattern

Editable architectural schematic

Structural features

Fibrous bands form a whorled or storiform configuration.

Lymphoplasmacytic inflammation is prominent.

The pattern suggests type 1 autoimmune pancreatitis in context.

Schematic — not a histologic specimen

Slide 36 · Obliterative phlebitis is a second defining clue

Editable architectural schematic

Nearly obliterated vein

Structural features

Inflammation and fibrosis involve venous walls.

The venous lumen may be obliterated.

Search for this in a mass-forming fibrosing pancreatic lesion.

Schematic — not a histologic specimen

Slide 37 · IgG4-positive plasma cells require pattern correlation

What supports type 1 AIP

Storiform fibrosis

Obliterative phlebitis

Rich lymphoplasmacytic infiltrate

Interpretive caution

IgG4 immunostaining provides supportive tissue information.

Do not reduce diagnosis to plasma-cell presence alone.

Slide 38 · Type 2 autoimmune pancreatitis centers on ducts

Type 2 AIP shows neutrophils invading pancreatic duct epithelium.

Neutrophils may also occupy lumina of medium-sized ducts.

These are granulocytic epithelial lesions.

Abundant IgG4-positive plasma cells typical of type 1 are absent.

Slide 39 · Granulocytic epithelial lesions define type 2 histology

Editable architectural schematic

Neutrophils in/at duct epithelium

Structural features

Neutrophils infiltrate ductal epithelium.

Neutrophils can accumulate in the duct lumen.

The injury has a conspicuously duct-centered distribution.

Schematic — not a histologic specimen

Slide 40 · Autoimmune pancreatitis: Compare types 1 and 2

Attribute

Type 1 AIP

Type 2 AIP

Systemic context

IgG4-related disease

Mainly pancreatic

Inflammatory feature

IgG4-rich plasma cells

Duct-associated neutrophils

Characteristic lesion

Storiform fibrosis / phlebitis

Granulocytic epithelial lesion

Clinical association

Systemic IgG4 disease

Sometimes ulcerative colitis

Slide 41 · Type 3 is described as treatment-related

Robbins 11th ed. Uses “type 3 AIP” for checkpoint-inhibitor–associated injury.

Described as uncommon and often mild, particularly with combination therapy.

Diagnosis is commonly based on imaging and enzyme abnormalities.

Histologic features remain incompletely established in the supplied source.

Slide 42 · A pancreatic head mass may be inflammatory

Autoimmune pancreatitis

Can produce a mass-like enlargement.

Often responds to glucocorticoid treatment.

Pancreatic carcinoma

Can also appear as a pancreatic head mass.

Distinguishing neoplasia before therapy is essential.

Slide 43 · Avoid treating every mass as autoimmune disease

Mass-forming pancreatitis and pancreatic carcinoma are consequential mimics.

Structural / mechanistic meaning

Histology, distribution, serology and imaging require integrated interpretation.

Clinical / interpretive meaning

Steroid responsiveness does not replace an appropriate malignancy assessment.

Slide 44 · Clinical symptoms may be episodic or persistent

Many patients have recurrent mild-to-moderately severe abdominal pain.

Others have persistent pain with radiation to the back.

Attacks may follow alcohol consumption or excessive food intake.

Opiates and drugs that increase sphincter-of-Oddi tone may precipitate attacks.

Slide 45 · Recurrent pain reflects persistent pancreatic injury

Chronic duct/parenchymal damage

Episodes of renewed injury

Abdominal or back pain

Repeated clinical presentations

Pain severity varies; There is no obligatory single symptom trajectory.

Slide 46 · Some patients present only after functional loss

Symptomatic pathway

Painful recurrent episodes

Investigation reveals a chronically injured gland

Silent pathway

Little or no preceding pain

Later malabsorption or diabetes reveals disease

Slide 47 · Exocrine failure disrupts intestinal digestion

Acinar destruction

Reduced digestive enzyme output

Impaired intraluminal digestion

Malabsorption

Weight loss

Exocrine damage provides a mechanistic explanation for nutritional decline.

Slide 48 · Weight loss is a consequence of malabsorption

Exocrine deficiency impairs nutrient digestion.

Malabsorption contributes to loss of body mass.

The clinical picture may be dominated by nutritional rather than pain symptoms.

Weight loss should be correlated with pancreatic structure and function.

Slide 49 · Hypoalbuminemia can lead to edema

Chronic malabsorption

Poor nutritional protein status

Reduced serum albumin

Lower plasma oncotic pressure

Peripheral edema

Edema is a secondary systemic consequence, not direct pancreatic swelling.

Slide 50 · Endocrine tissue loss produces diabetes

Progressive tissue destruction

Eventually islet-cell loss

Impaired endocrine function

Diabetes mellitus

Relative islet sparing on early histology does not rule out late diabetes.

Slide 51 · Serum amylase has limited sensitivity in chronic disease

During an attack

Mild-to-moderate amylase elevation may occur.

Mild fever may accompany active inflammation.

Advanced disease

Extensive acinar loss may blunt enzyme release.

A normal value does not exclude chronic pancreatitis.

Slide 52 · Imaging provides structural evidence

Computed tomography can visualize pancreatic calcifications.

Ultrasonography can also demonstrate calcified intrapancreatic concretions.

Correlate imaging with symptoms, functional loss, and likely etiologic group.

Ductal distortion and pancreatic fibrosis help explain chronicity.

Slide 53 · Biliary obstruction changes the presentation

Gallstone-related obstruction

Impaired biliary drainage

Cholestatic biochemical abnormalities

Possible jaundice

Alkaline phosphatase elevation and jaundice with obstruction.

Slide 54 · Diagnosis requires convergent evidence

Clinical context

Recurrent upper abdominal/back pain or silent progressive insufficiency.

Etiologic clues

Alcohol, obstruction, hereditary predisposition, or autoimmunity.

Structure

Scarring, duct dilation, concretions or mass-like inflammation.

Function/laboratory

Malabsorption, diabetes; Amylase may be normal.

Slide 55 · Pseudocysts are a recognized complication

Pseudocysts may follow pancreatitis, particularly attacks on chronic alcoholic disease.

They arise when pancreatic/peripancreatic necrotic injury is walled off.

Pseudocysts in about 10% of chronic pancreatitis cases.

Larger lesions may compress or erode adjacent structures.

Slide 56 · Pseudocyst walls lack an epithelial lining

Pseudocyst

Fibrous and granulation-tissue wall

No true epithelial lining

True cyst (conceptual contrast)

An epithelial lining is present.

Cystic lesions require etiologic distinction.

Slide 57 · Long-term morbidity extends beyond abdominal pain

Exocrine dysfunction

Chronic malabsorption and nutritional consequences.

Endocrine dysfunction

Diabetes mellitus in late-stage damage.

Pain

Persistent or recurrent severe pain.

Local sequelae

Pancreatic pseudocyst formation.

Slide 58 · Interpret historical survival figures cautiously

Approximately 50% mortality over 20–25 years.

Structural / mechanistic meaning

The figure describes long-term prognosis in its textbook context; No cohort or era is specified in the excerpt.

Clinical / interpretive meaning

Do not interpret this figure as an individualized prognosis or as a contemporary risk estimate.

Slide 59 · Case: Painful calcific pancreatic disease

Clinical vignette

A middle-aged patient with prolonged heavy alcohol exposure reports recurrent epigastric/back pain. CT demonstrates intrapancreatic calcifications.

Reason through the findings

Which morphologic features are predicted?

Why might serum amylase be nondiagnostic?

Expected findings: Fibrotic acinar loss, distorted/dilated ducts and concretions; Extensive acinar dropout may blunt enzyme release.

Slide 60 · Case: Mass-forming autoimmune pancreatitis

Clinical vignette

Imaging shows a focal pancreatic head enlargement. Tissue examination demonstrates dense lymphoplasmacytic inflammation and storiform fibrosis.

Reason through the findings

Which autoimmune subtype is most consistent?

What additional tissue feature should be sought?

Type 1 AIP is favored; Assess obliterative phlebitis and IgG4-positive plasma cells while excluding carcinoma.

Slide 61 · Case: Recurrent pancreatitis beginning in childhood

Clinical vignette

A patient experienced repeated episodes of acute pancreatitis beginning in childhood and now has pancreatic fibrosis.

Reason through the findings

Which pathogenic axis suggests hereditary disease?

Which three genes deserve initial conceptual emphasis?

Failure of normal trypsin regulation or duct secretion; PRSS1, SPINK1 and CFTR.

Slide 62 · Morphology, mechanism and symptoms reinforce each other

Repeated injury / specific immune process

Stellate-cell activation and fibrosis

Acinar atrophy + duct changes

Exocrine insufficiency ± pain

Late endocrine failure

A unified causal chain explains most important clinicopathologic observations.

Slide 63 · Five findings to retain

Chronic pancreatitis means irreversible acinar loss and fibrosis.

Alcohol, obstruction, genetic predisposition and autoimmune injury are key causes.

Stellate-cell activation under TGF-β/PDGF signaling produces scar.

Type 1 AIP has storiform fibrosis and phlebitis; Type 2 has ductal neutrophils.

Chronic pain, malabsorption, diabetes and pseudocysts reflect structural injury.

Slide 64 · Reference and source boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Elsevier; 2026.

Textbook discussion: chronic pancreatitis — pathogenesis, morphology, and clinical features.

Also covered: inherited predisposition to pancreatitis and major implicated genes.

Also covered: postpancreatitis pseudocysts and their lack of an epithelial lining.

All glandular and microscopic illustrations are original editable schematics, not diagnostic tissue images.